ArticleTrials2026

PRIMA: randomized prospective multicenter non-inferiority study for primary diagnosis of clinically significant PRostate cancer by PSA and MR IMAging-study protocol for a randomized diagnostic accuracy trial.

Rouvier Al-Monajjed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.